Loading company…
ReceptIcon ApS is an Aarhus-based biotechnology company developing receptor antagonists that prevent therapeutics from accumulating in the kidney.
Founded in 2001 and based in Aarhus, Denmark, ReceptIcon ApS is a biotechnology company. It develops receptor antagonists that prevent accumulation of therapeutics in the kidney. The company is in the healthcare sector and its stage is recorded as Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in